A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma

NCT02087878 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Strategic considerations

Conditions

Sponsor

AbbVie